← FDA Drug Approvals (Drugs@FDA)

SAFINAMIDE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2024-12-31

Drug application

FDA Application #
ANDA215978
Application type
Abbreviated New Drug Application (Generic)
Brand name
SAFINAMIDE MESYLATE
Generic name
Safinamide Mesylate
Active ingredients
SAFINAMIDE MESYLATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
MSN
First approval
2024-12-31

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown